Flexprint substrate enzyme sensor for determination of daily glucose-profiles for diabetic patients

The goal is to develop a miniaturized system allowing continuous measurement of glucose concentration profiles over 24 hours for several days. The unique feature of the PharmaSens / IMT approach lies in the insertion mechanism and the needle size to assure optimum user-friendliness and patient comfort. The measurement method is based on classical amperometric detection using an enzymatic membrane. The sensor substrate is made on a flexprint substrate and consists of a 3-electrode cell on a needle-shaped tip of ~100 μm width and is covered with polymeric membranes. The sensor is integrated in a device that combines the insertion mechanism and electronics.


Presented at:
MMB2011, Lucerne, Switzerland, May 4-6, 2011
Year:
2011
Laboratories:




 Record created 2011-05-16, last modified 2018-03-17


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)